More good data for benralizumab (IL5i) in EGPA, @TerrierBen There may be additional benefit over MEPO given deeper eosinophil depletion Checkout our recent editorial about this in @TheLancetRheum @RheumNow #ACR23 https://t.co/1d2nITOuOs